InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,572.85
(
0.10%
)
US TECH 100
19,908.00
(
0.31%
)
Dow Jones
39,344.79
(
-0.08%
)
Brent Oil
85.43
(
-1.25%
)
Bitcoin
56,523.82
(
1.21%
)
Post# of 252522
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

RockRat

Send PM Follow Ignore
Followers 11
Posts 903
Boards Moderated 0
Alias Born 12/19/2005

RockRat

Re: DewDiligence post# 215121

Tuesday, 11/14/2017 10:35:01 PM

Tuesday, November 14, 2017 10:35:01 PM

Post# of 252522
ACHN also reported some early data for C3G. n=2 and open label, but signal was good enough to demonstrate proof of concept and move along. I have a position, and think this may be a good time to add on the weakness. With the Hep C program dead and the J&J overhang gone, this is an interesting play on their complement factor D inhibition program.

Regards, RockRat
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up